Medicinal Immunoglobulin G Products (2020) Show High Infectivity Neutralizing Activity Against Seasonal Influenza Virus Strains Selected for Future Vaccines (2020–2022)

Immunoglobulin (Ig)G medicinal products manufactured in 2020 were tested for infectivity neutralization and hemagglutination inhibition against World Health Organization-selected influenza strains included in worldwide vaccines 2020–2022. The IgG batches (from US plasma) showed potent activity. Intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Díez, José María, Casals, Daniel, Romero, Carolina, Gajardo, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253882/
https://www.ncbi.nlm.nih.gov/pubmed/35794931
http://dx.doi.org/10.1093/ofid/ofac216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253882/
https://www.ncbi.nlm.nih.gov/pubmed/35794931
http://dx.doi.org/10.1093/ofid/ofac216

Ejemplares similares